Free Trial

Eun Yang Analyst Performance

Analyst at Jefferies Financial Group

Eun Yang is a stock analyst at Jefferies Financial Group focused in the medical sector, covering 22 publicly traded companies. Over the past year, Eun Yang has issued 5 stock ratings, including buy and hold recommendations. While full access to Eun Yang's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Eun Yang's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions.

Analyst Rankings, Coverage, and Performance Statistics

Average Return
00.00% 12-Month ROI
Success Rate
00.00% Profitable Ratings
Total Ratings
61 Last 10 Years
Buy Recommendations
83.33% 50 Buy Ratings
Companies Covered
22 Unique Companies

Ratings Distribution

RatingPercentageCount
Strong Buy0.0%0 ratings
Buy83.3%50 ratings
Hold11.7%7 ratings
Sell5.0%3 ratings

Out of 60 total stock ratings issued by Eun Yang at Jefferies Financial Group, the majority (83.3%) have been Buy recommendations, followed by 11.7% Hold and 5.0% Sell.

Exchange Coverage

ExchangePercentageCount
NASDAQ
100.0% of companies on NASDAQ
22 companies

Eun Yang, an analyst at Jefferies Financial Group, currently covers 22 companies listed on , with the majority traded on NASDAQ.

Coverage Focus

Sector IconSectorPercentage
Medical
20 companies
90.9%
Energy
1 company
4.5%
Aerospace
1 company
4.5%

Eun Yang of Jefferies Financial Group specializes in stock coverage within the Medical sector, with additional focus on Energy and Aerospace companies.

Coverage Industries

IndustryPercentage
MED - BIOMED/GENE
14 companies
63.6%
MED - DRUGS
4 companies
18.2%
MED - GENERIC DRG
1 company
4.5%
PHARMACEUTICAL PREPARATIONS
1 company
4.5%
SOLAR
1 company
4.5%
AEROSP/DEF EQ
1 company
4.5%

About Eun Yang

Eun K. Yang is currently working as an Equity Analyst at Jefferies LLC. Prior to this, Dr. Yang worked as a Senior Analyst at Wachovia Capital Markets LLC from 2004 to 2005.

Eun Yang's Ratings History at Jefferies Financial Group

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription
12-Month ROIUpgrade to All Access to use the All ROI Filter
CompanyReport DateActionReport Date Price12-Month
Price Target
Rating12-Month
Price & ROI
Details
United Therapeutics Corporation stock logo
UTHR
United Therapeutics
3/2/2026Reiterated Rating$513.82Buy
Generation Bio Co. stock logo
GBIO
Generation Bio
12/16/2025Downgrade$5.39$5.00Hold
Rigel Pharmaceuticals, Inc. stock logo
RIGL
Rigel Pharmaceuticals
11/5/2025Upgrade$37.85$42.00Buy
Astria Therapeutics, Inc. stock logo
ATXS
Astria Therapeutics
10/14/2025Downgrade$11.75$13.00Hold
United Therapeutics Corporation stock logo
UTHR
United Therapeutics
9/2/2025Boost Price Target$411.21$564.00Buy